Suvichada Assawakosri

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Venues

PloS one

Vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Jiratchaya Puenpa, Sitthichai Kanokudom, Suvichada Assawakosri, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanatorn, Siriporn Songtaisarana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study. PloS one 18 (4) (2023)
Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Jiratchaya Puenpa, Sitthichai Kanokudom, Suvichada Assawakosri, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanatorn, Siriporn Songtaisarana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study. PloS one 18 (4) (2023)
Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Jiratchaya Puenpa, Sitthichai Kanokudom, Suvichada Assawakosri, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanatorn, Siriporn Songtaisarana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study. PloS one 18 (4) (2023)
Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Jiratchaya Puenpa, Sitthichai Kanokudom, Suvichada Assawakosri, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanatorn, Siriporn Songtaisarana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study. PloS one 18 (4) (2023)
Nungruthai Suntronwong, Ritthideach Yorsaeng, Jiratchaya Puenpa, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Sitthichai Kanokudom, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Suvichada Assawakosri, Pornjarim Nilyanimit, Sirapa Klinfueng, Lakkhana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron. Vaccines 10 (3) (2022)
Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Ritthideach Yorsaeng, Donchida Srimuan, Thaksaporn Thatsanatorn, Sirapa Klinfueng, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine. Vaccines 10 (1) (2022)

Suvichada Assawakosri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Suvichada Assawakosri